Cytovale Funding & Investors
San Francisco, CA
Cytovale Inc. operates as a commercial physical and biological research and development firm. The Company develops novel microfluidic platform which allows users to probe individual cells to quantify the mechanical signatures of disease. Cytovale serves customers in the State of California.
cytovale.comTotal Amount Raised: $228,589,600
Cytovale Funding Rounds
Series D
$100,000,000
Series D Investors
Alumni Ventures GroupSands Capital ManagementBreakout VenturesWells FargoGlobal Health InvestmentCPP Investment BoardSeries C
$84,000,000
Series C Investors
Alumni Ventures GroupWells FargoSands Capital ManagementGlobal Health InvestmentDebt Financing
$16,435,000
Debt Financing Investors
Blackhorn VenturesPathway BioventuresBreakout VenturesDolby Family VenturesSeries B
$15,000,000
Series B Investors
Breakout VenturesBlackhorn VenturesWestech Investment AdvisorsGRIDS CapitalSeries B
$7,249,989
Series B Investors
Blackhorn VenturesBreakout VenturesIT-FarmGrant
$1,419,607
Grant Investors
National Science FoundationSeries A
$4,300,000
Series A Investors
Dolby Family VenturesGrant
$184,998
Grant Investors
National Science Foundation
Funding info provided by Diffbot.